Spots Global Cancer Trial Database for A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
Official Title: A PROSPECTIVE REGISTRY TO ASSESS THE EFFECTIVENESS AND LOCAL TOLERABILITY OF INTRAVESICAL VALRUBICIN IN SUBJECTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Study ID: NCT01314664
Interventions
Study Description
Brief Summary: The purpose of this study is to observe and describe the effectiveness and local tolerability of intravesical treatment with valrubicin for non-muscle invasive bladder cancer (NMIBC) in a cohort of subjects treated under routine practice conditions.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
BCG Oncology, Phoenix, Arizona, United States
Urology Research Network, Hialeah, Florida, United States
Advanced Urology Association of Florida, Vero Beach, Florida, United States
Kansas City Urology Care, Overland Park, Kansas, United States
Delaware Valley Urology, Sewell, New Jersey, United States
Delaware Valley Urology, Voorhees, New Jersey, United States
Long Island Urological Associates, Bethpage, New York, United States
Urologic Consultants of SE PA, Bala-Cynwyd, Pennsylvania, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Urology Associates of North Texas, Arlington, Texas, United States
Urology Clinics of North Texas, Dallas, Texas, United States
Contact Details
Name: Todd Kirby, PhD
Affiliation: Endo
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
